BeStock  
Stocks › Biotechnology › MIRM

Mirum Pharmaceuticals MIRM

US equityMarket cap rank #1818Biotechnology
$96.13 +$0.62 (+0.65%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $96.13 0.00%
Open$94.50
Prev close$95.51
Day range$94.10 – $98.39
Volume1.06M
Market cap$6.28B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership114.9%+2.04 pts vs. prior quarter
Institutions holding413+6 vs. prior quarter
Insider trades (recent)26 buys / 23 sellsNet buying
Short interest10.05% of floatDays to cover 11.8 · as of 30 Oct 2026
Short-sale volume share22.0%5-day average of daily volume

Short-sale volume as % of daily volume

9%18%26%35%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$2.85M (9 inflow days, 11 outflow days).

Net flow by order size, last 20 sessions

−$5.2MSuper+$2.4MBig+$2.2MMid+$5.1MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 38.4% of shares outstanding.

Largest holders

  • Frazier Life Sciences Management, LP11.76%
  • Janus Henderson Group plc9.05%
  • BlackRock7.24%
  • FMR6.24%
  • T. Rowe Price Group, Inc.4.07%
  • Vanguard Portfolio Management, LLC4.03%
  • Vanguard Capital Management, LLC3.83%
  • State Street Global Advisors3.66%

By investor type

  • Mutual Fund80.09%
  • VC/PE Fund16.72%
  • Hedge Fund11.57%
  • Public Company3.14%
  • Private Company1.66%
  • Individual/Insider1.33%
  • Government Pension Fund0.69%
  • Insurance Company0.32%

Reported short interest has risen from 9.99% to 10.05% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
FMR Mutual Fund 2026/Q3 +403,449 6.2%
UBS Asset Management Mutual Fund 2026/Q3 +342,383 1.2%
BlackRock Mutual Fund 2026/Q3 +333,232 7.2%
Thrivent Investment Management, Inc. Mutual Fund 2026/Q3 +303,475 0.5%
Jane Street Group, LLC Private Company 2026/Q3 +285,369 0.4%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +256,559 4.0%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +244,446 3.8%
State Street Global Advisors Mutual Fund 2026/Q3 +219,992 3.7%
Fisher Investments Mutual Fund 2026/Q3 +113,723 0.3%
Franklin Resources Mutual Fund 2026/Q3 +104,808 1.9%
Impax Asset Management Group Plc Mutual Fund 2026/Q3 +100,000 0.2%
FMR Mutual Fund 2026/Q3 +1,704,945 5.7%
William Blair Investment Management, LLC Mutual Fund 2026/Q3 +1,108,302 2.2%
Invesco Ltd. Mutual Fund 2026/Q3 +1,096,862 2.1%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +944,936 3.7%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
10 Nov 2026 Laura Brege Independent Director Derivative Exercise and Sale -14,167 $94.74 15,703
3 Nov 2026 Joanne M. Quan Former Chief Medical Officer Intent to Sell (Form 144) -14,684 $96.97 –
3 Nov 2026 Christopher Peetz Chief Executive Officer Derivative Exercise and Sale -20,000 $90.00 394,137
15 Oct 2026 Jolanda Howe Senior VP & Global Controller Derivative Exercise and Retained +16,112 $19.24 16,728
8 Oct 2026 Rob Myers Chief Medical Officer Other Derivative Acquisition +25,000 – 25,000
8 Oct 2026 Rob Myers Chief Medical Officer Other Derivative Acquisition +40,000 $86.01 40,000
5 Oct 2026 Christopher Peetz Chief Executive Officer Derivative Exercise and Retained +12,197 $19.19 394,137
20 Sep 2026 Rob Myers Chief Medical Officer Initial Statement of Beneficial +0 – 55
13 Sep 2026 Eric Bjerkholt Chief Financial Officer Intent to Sell (Form 144) -9,943 $98.37 –
13 Sep 2026 Eric Bjerkholt Chief Financial Officer Derivative Exercise and Sale -9,943 $98.37 44,745
10 Sep 2026 Eric Bjerkholt Chief Financial Officer Derivative Exercise and Retained +8,390 – 44,745
1 Sep 2026 Jolanda Howe Senior VP & Global Controller Automatic Disposition -658 $100.00 616
31 Aug 2026 Christopher Peetz Chief Executive Officer Derivative Exercise and Sale -30,000 $98.91 381,940
17 Aug 2026 Jolanda Howe Senior VP & Global Controller Derivative Exercise and Sale -40,000 $100.00 1,274
10 Aug 2026 Eric Bjerkholt Chief Financial Officer Automatic Disposition -6,001 $99.90 36,355
9 Aug 2026 Christopher Peetz Chief Executive Officer Derivative Exercise and Sale -20,000 $100.14 381,809
2 Aug 2026 Jolanda Howe Senior VP & Global Controller Automatic Disposition -1,840 $105.29 1,274
5 Jul 2026 Eric Bjerkholt Chief Financial Officer Automatic Disposition -5,000 $124.94 42,181
5 Jul 2026 Christopher Peetz Chief Executive Officer Derivative Exercise and Sale -20,000 $124.79 381,809
30 Jun 2026 Jolanda Howe Senior VP & Global Controller Automatic Disposition -2,721 $120.00 3,114

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 6,523,716 10.0% 11.8
15 Oct 2026 6,663,045 10.3% 7.3
30 Sep 2026 6,985,385 10.8% 7.7
15 Sep 2026 6,281,413 9.7% 12.0
31 Aug 2026 6,171,979 9.5% 13.2
14 Aug 2026 6,489,383 10.0% 7.3

Discussion

No comments yet — be the first to weigh in on MIRM.

Sign in to join the discussion.

Scroll to Top